Combination of an IAP-inhibitor and a taxane7

Details for Australian Patent Application No. 2006331964 (hide)

Owner Novartis AG

Inventors Straub, Christopher Sean; Jensen, Michael Rugaard; Wang, Youzhen; Tran, Mary Ann; Zawel, Leigh

Agent Davies Collison Cave

Pub. Number AU-A-2006331964

PCT Pub. Number WO2007/075525

Priority 60/752,146 20.12.05 US

Filing date 18 December 2006

Wipo publication date 5 July 2007

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/425 (2006.01) - Thiazoles

A61K 31/475 (2006.01) - having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/075525 Priority application(s): WO2007/075525

26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006331965-Methods and systems for leaching silicone hydrogel ophthalmic lenses

2006331963-Substituted piperidines as calcium channel blockers